Researchers continue to excited about the medication , a innovative dual agonist showing promising data in initial trials for body management. It functions by impacting two systems: GLP-1 and GIP, that , when stimulated, help regulate cravings and enhance metabolism . Early reports indicate noteworthy weight reduction and likely improvements for pa